The Curtin Health Innovation Research Institute (CHIRI)

The Curtin Health Innovation Research Institute (CHIRI) is dedicated to developing new treatments for diseases that more commonly occur with older age.

CHIRI’s vision is to identify new prevention and treatment strategies for adult diseases by supporting researchers who are prepared to explore the unexplored and take risks in research in search of major scientific insights and adult health outcomes. CHIRI’s research is focused on four key areas, covering major disorders and diseases that impact on the quality of adult life.


Identifying new treatments for age-associated blood vessel disorders including bleeding and clotting disorders, heart disease and stroke. Targeting blood vessel growth and function to treat age-associated cancers, blood-vessel inflammatory disorders with ageing, age-linked energy disorders, liver disorders and age-associated infectious diseases.


Stopping the decline in immune function with ageing, targeting the immune system to treat adult cancers and immune function for treatment of infection and muscle repair.


Exploring novel and new approaches to the prevention and treatment of Alzheimer’s disease and other dementias, as well as the prevention and treatment of neurodegenerative diseases such as multiple sclerosis and epilepsy.


Researching novel interventions for age-associated cancers such as breast, pancreas and prostate cancer, with a focus on how the immune system influences cancer risk and progression and trialing novel interventions.